	Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era. Cancer J Lu BY, Goldberg SB. PMID: 42497398 [PubMed - indexed for MEDLINE]
	Optimizing the Care of Patients With Locally Advanced NSCLC With Multimodality Therapy. Cancer J Mohammed M, McCall NS, Higgins KA. PMID: 42497397 [PubMed - indexed for MEDLINE]
	Early-Stage NSCLC: Novel Surgical Techniques and Neoadjuvant, Adjuvant, and Perioperative Therapies. Cancer J Kim SY, Woodard G. PMID: 42497396 [PubMed - indexed for MEDLINE]
	Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA. Cancer J Trejo Bittar HE, Dacic SE. PMID: 42497395 [PubMed - indexed for MEDLINE]
	The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy. Cancer J Boiarsky D, Vokes N. PMID: 42497394 [PubMed - indexed for MEDLINE]
	Targeting Oncogenic Gene Fusions in Lung Cancer. Cancer J Nie Y, Wilson FH. PMID: 42497393 [PubMed - indexed for MEDLINE]
	KRAS-mutated Non-Small Cell Lung Cancer: Drugging the Undruggable. Cancer J El Saadany T, Aeschlimann N, Sacher A. PMID: 42497392 [PubMed - indexed for MEDLINE]
	A Quarter Century of Transformation: Integrating Molecular Stratification and Immune Modulation Across the Continuum of Non-Small-Cell Lung Cancer. Cancer J Nassar AH, Halawi J, Herbst RS. PMID: 42497391 [PubMed - indexed for MEDLINE]
	Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study. J Clin Oncol Zhao Y, Zhao H, Wang Q, Yang K, Li Y, Fu Z, Yang W, He Z, Wang Y, Ma Y, Yang Y, Fang W, Xiao S, Zhu H, Zhu Y, Zhang L, Huang Y. PMID: 42497381 [PubMed - as supplied by publisher]
	Interpretable dynamic quantitative vascular morphometry features using SHAP for anti-angiogenic therapy response prediction. Sci Adv Hu K, Cai Q, Xu J, Ai S, Ou W, Liu Y. PMID: 42497260 [PubMed - indexed for MEDLINE]
	Deep Learning-Based Lung Cancer Segmentation and Volumetric Analysis Using CT Imaging: A Comprehensive Survey. Ann Biomed Eng Tezel TG, Turkan M, Sayilgan E. PMID: 42496940 [PubMed - as supplied by publisher]
	A prognostic analysis of lung cancer surgery in super-elderly patients: a multicenter real-world data study. Surg Today Hayama M, Okazaki M, Suzawa K, Shien K, Fujiwara T, Hirami Y, Watanabe M, Okutani D, Nishikawa H, Ueno T, Otani S, Matsuda E, Yaginuma H, Toyooka S. PMID: 42496895 [PubMed - as supplied by publisher]
	Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey. Fam Cancer Cerbone L, Perrino M, Grosso F, Ganzinelli M, Lo Russo G, Pasello G, Zucali PA, Ceresoli GL, Occhipinti M, Sculco M, on the behalf of MET-I (Mesothelioma team Italy). PMID: 42496771 [PubMed - indexed for MEDLINE]
	Development and Internal Validation of a Patient-Level Diagnostic Model Integrating Folate Receptor-Positive Circulating Tumor Cells and Peripheral CD8 Count for Malignant-Versus-Benign Pathology Discrimination in a Pathology-Enriched Pulmonary Nodule Cohort. Thorac Cancer Zhang C, Sun X, Su H, Liu Y, Gong L, Ma X, Zhang W, Sun F. PMID: 42496100 [PubMed - indexed for MEDLINE]
	Primary and acquired resistance to immunotherapy in NSCLC. Front Immunol Yuan B, Deng W, Luo J, Xin Y, Jiang X, Liu X, Cai Q. PMID: 42495623 [PubMed - indexed for MEDLINE]
	Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer. Front Immunol Chen W, Liang Y, Hou Q, Cao X, Zhao A, Wu B, Zhou Y, Zhang W, Zhao M, Yao N, Li F, Duan J, Zhang S, Li N, Cao J. PMID: 42495622 [PubMed - indexed for MEDLINE]
	Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer. Front Immunol Sequero-Lopez S, Castillo-Barnes D, Gálvez-Carvajal L, Palazón-Carrión N, Martínez-Murcia FJ, de la Cruz-Merino L, Muñoz-Couselo E, Provencio M, Ortiz A, Górriz JM, Ramírez J, Rueda-Domínguez A, Blancas I. PMID: 42495619 [PubMed - indexed for MEDLINE]
	Price trend, clinical benefit and within-class competition of drugs for metastatic Non-small cell lung cancer in China: a retrospective cohort study. Lancet Reg Health West Pac Du X, Luo X, Zhang H, Shen T, Wang X, Guo Q, Lv X, Zhao X, Pu Y, Yang Y, Huang L, Zhang Y. PMID: 42495089 [PubMed]
	Editorial: Advancing diagnostic excellence in early lung cancer detection. Front Oncol Kim RY, Kammer MN, Kim YW. PMID: 42494589 [PubMed]
	An interpretable multi-task whole-slide histopathology AI model for non-small cell lung cancer: Cross-cohort generalisation, spatial attention-transcriptomic integration, and molecular-immune profiling. Clin Transl Med Lu R, Lin A, Jiang A, Feng Y, Fang X, Shen J, Bai Y, Peng S, Zhang J, Cheng Q, Feng S, Li Q, Luo P. PMID: 42494157 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 161753

Page 1 of 8088



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy